middle.news

Biome Australia Unveils Promising Clinical Data for Probiotic Strain BMB18

8:24am on Thursday 30th of January, 2025 AEDT Health Care
Read Story

Biome Australia Unveils Promising Clinical Data for Probiotic Strain BMB18

8:24am on Thursday 30th of January, 2025 AEDT
Key Points
  • BMB18 probiotic strain shows immune modulation and inflammation reduction
  • Demonstrated antioxidant activity and improved intestinal barrier integrity
  • Findings support potential applications in chronic intestinal and inflammatory diseases
  • Data to guide future clinical trials and commercial product development
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Biome Australia (ASX:BIO)
OPEN ARTICLE